2. Apoptosis
  3. c-Myc
  4. VPC-70619

VPC-70619 is a potent N-Myc inhibitor. VPC-70619 blocks the binding of the N-Myc-Max heterocomplex to the DNA E-box and exhibits potent inhibitory activity against N-Myc-dependent cell lines. VPC-70619 can partially reverse paclitaxel (HY-B0015) resistance in cells by reducing MYCN expression. VPC-70619 can be used for cancer research (e.g., neuroblastoma and thyroid cancer).

Para uso exclusivo en investigación. No vendemos a pacientes.

VPC-70619

VPC-70619 Estructura química

No. CAS : 2361742-30-3

Tamaño Precio Stock Cantidad
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
 En stock
Solution
10 mM * 1 mL in DMSO En stock
Solid
5 mg En stock
10 mg En stock
25 mg En stock
50 mg En stock
100 mg En stock
200 mg   Obtener un presupuesto  
500 mg   Obtener un presupuesto  

* Seleccione Cantidad antes de agregar artículos.

This product is a controlled substance and not for sale in your territory.

Revisión del cliente

Based on 2 publication(s) in Google Scholar

VPC-70619 Related Antibodies

Top Publications Citing Use of Products

  • Actividad biológica

  • Pureza y Documentación

  • Referencias

  • Revisión del cliente

Descripciòn

VPC-70619 is a potent N-Myc inhibitor. VPC-70619 blocks the binding of the N-Myc-Max heterocomplex to the DNA E-box and exhibits potent inhibitory activity against N-Myc-dependent cell lines. VPC-70619 can partially reverse paclitaxel (HY-B0015) resistance in cells by reducing MYCN expression. VPC-70619 can be used for cancer research (e.g., neuroblastoma and thyroid cancer)[1][2].

In Vitro

VPC-70619 (10 μM) exhibits an inhibition rate of 99.4% in IMR32 cells, while only 14.1% in HO15.19 cells[1].
VPC-70619 (1-10 μM) is shown to be highly stable with a T1/2 of 2310 min in In liver microsomes[1].
VPC-70619 upregulates the mRNA levels of MYCN, MDM2, and CRABP2, and downregulates TGM2 and INHBA, confirming its specific regulatory effect on the MYCN signaling pathway in SW1736-PTX and 8505C-PTX cells[2].
VPC-70619 (0.5-30 μM, 0-72 h) inhibits the proliferation, migration and aggressiveness of SW1736-PTX and 8505C-PTX cells, and the effect is enhanced when combined with Paclitaxel[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

VPC-70619 Related Antibodies
Parmacokinetics
Species Dose Route Cmax Tmax T1/2
Mice[1] 10 mg/kg i.p. 29500 ng/mL 60 min 330 min
Mice[1] 10 mg/kg p.o. 24000 ng/mL 480 min 427 min
Peso molecular

364.71

Fòrmula

C16H8ClF3N4O
No. CAS
Appearance

Solid

Color

Off-white to light yellow

SMILES

N#CC1=CC(C(F)(F)F)=C(C=C1)NNC(C2=CC=C(C(Cl)=C2)C#N)=O
Envío

Room temperature in continental US; may vary elsewhere.
Almacenamiento
Powder -20°C 3 years
In solvent -80°C 6 months
-20°C 1 month
Solvente y solubilidad
In Vitro: 

DMSO : ≥ 100 mg/mL (274.19 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

*"≥" means soluble, but saturation unknown.

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.7419 mL 13.7095 mL 27.4190 mL
5 mM 0.5484 mL 2.7419 mL 5.4838 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Calculadora de molaridad

  • Calculadora de dilución

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
Pureza y Documentación
Referencias

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 2.7419 mL 13.7095 mL 27.4190 mL 68.5476 mL
5 mM 0.5484 mL 2.7419 mL 5.4838 mL 13.7095 mL
10 mM 0.2742 mL 1.3710 mL 2.7419 mL 6.8548 mL
15 mM 0.1828 mL 0.9140 mL 1.8279 mL 4.5698 mL
20 mM 0.1371 mL 0.6855 mL 1.3710 mL 3.4274 mL
25 mM 0.1097 mL 0.5484 mL 1.0968 mL 2.7419 mL
30 mM 0.0914 mL 0.4570 mL 0.9140 mL 2.2849 mL
40 mM 0.0685 mL 0.3427 mL 0.6855 mL 1.7137 mL
50 mM 0.0548 mL 0.2742 mL 0.5484 mL 1.3710 mL
60 mM 0.0457 mL 0.2285 mL 0.4570 mL 1.1425 mL
80 mM 0.0343 mL 0.1714 mL 0.3427 mL 0.8568 mL
100 mM 0.0274 mL 0.1371 mL 0.2742 mL 0.6855 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

VPC-70619 Related Classifications

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

VPC-706192361742-30-3VPC70619VPC 70619c-MycMycDNABioavailabilityIMR32NCI-H660 cellsHO15.19 cellsThyroid cancerPaclitaxelDrug resistanceBromodomainInhibitorinhibitorinhibit

Productos vistos recientemente:

Consulta en línea

Your information is safe with us. * Required Fields.

Nombre del producto

  

Requested Quantity *

Nombre del solicitante *

 

Saludo

Direcciòn del E-mail *

 

Número de teléfono *

Department

 

Nombre de la Organizaciòn *

City

Provincia

Country or Region *

      

Observaciones

Consulta para venta a granel

Inquiry Information

Nombre del producto:
VPC-70619
Cat. No.:
HY-144878
Cantidad:
MCE Japan Authorized Agent:

Revisión del cliente

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Nombre del producto

  

Lot #

Nombre del solicitante *

 

Direcciòn del E-mail *

Número de teléfono

 

Department *

Nombre de la Organizaciòn *

 

Country or Region *

Observaciones

SAFETY DATA SHEET (SDS)

English - EN (252 KB) Français - FR (252 KB) Deutsch - DE (252 KB) Norwegian - NO (252 KB) Español - ES (252 KB) Swedish - SV (252 KB) Italian - IT (252 KB) Korean - KR (252 KB) Portuguese - PT (252 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.